190 related articles for article (PubMed ID: 17688667)
1. Serum levels of stem cell factor and thrombopoietin are markedly decreased in fulminant hepatic failure patients with a poor prognosis.
Okumoto K; Saito T; Onodera M; Sakamoto A; Tanaka M; Hattori E; Haga H; Ito JI; Sugahara K; Saito K; Togashi H; Kawata S
J Gastroenterol Hepatol; 2007 Aug; 22(8):1265-70. PubMed ID: 17688667
[TBL] [Abstract][Full Text] [Related]
2. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure.
Lin SD; Kawakami T; Ushio A; Sato A; Sato S; Iwai M; Endo R; Takikawa Y; Suzuki K
J Gastroenterol Hepatol; 2006 Feb; 21(2):374-80. PubMed ID: 16509861
[TBL] [Abstract][Full Text] [Related]
3. Liver regeneration in fulminant hepatitis as evaluated by serum transforming growth factor alpha levels.
Tomiya T; Fujiwara K
Hepatology; 1996 Feb; 23(2):253-7. PubMed ID: 8591849
[TBL] [Abstract][Full Text] [Related]
4. Serum thrombopoietin and erythropoietin levels in patients with acute promyelocytic leukaemia during all-trans retinoic acid treatment.
Kinjo K; Kizaki M; Takayama N; Michikawa N; Oda A; Okamoto S; Tahara T; Kato T; Miyazaki H; Ikeda Y
Br J Haematol; 1999 May; 105(2):382-7. PubMed ID: 10233408
[TBL] [Abstract][Full Text] [Related]
5. Serum hepatocyte growth factor in acute hepatic failure in comparison with acute hepatitis.
Shiota G; Okano J; Umeki K; Kawasaki H; Kawamoto T; Nakamura T
Res Commun Mol Pathol Pharmacol; 1994 Aug; 85(2):157-62. PubMed ID: 7994560
[TBL] [Abstract][Full Text] [Related]
6. Thrombopoietin in acute liver failure.
Schiødt FV; Balko J; Schilsky M; Harrison ME; Thornton A; Lee WM;
Hepatology; 2003 Mar; 37(3):558-61. PubMed ID: 12601353
[TBL] [Abstract][Full Text] [Related]
7. Hepatic thrombopoietin mRNA levels in acute and chronic liver failure of childhood.
Wolber EM; Ganschow R; Burdelski M; Jelkmann W
Hepatology; 1999 Jun; 29(6):1739-42. PubMed ID: 10347116
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome c is a possible new marker for fulminant hepatitis in humans.
Sakaida I; Kimura T; Yamasaki T; Fukumoto Y; Watanabe K; Aoyama M; Okita K
J Gastroenterol; 2005 Feb; 40(2):179-85. PubMed ID: 15770402
[TBL] [Abstract][Full Text] [Related]
9. Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.
Aw MM; Mitry RR; Hughes RD; Dhawan A
J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):224-7. PubMed ID: 17255836
[TBL] [Abstract][Full Text] [Related]
10. SCF and IL-31 rather than IL-17 and BAFF are potential indicators in patients with allergic asthma.
Lei Z; Liu G; Huang Q; Lv M; Zu R; Zhang GM; Feng ZH; Huang B
Allergy; 2008 Mar; 63(3):327-32. PubMed ID: 18053009
[TBL] [Abstract][Full Text] [Related]
11. [Study on the influencing factors of thrombocytopenia in viral hepatitis].
Jiang XH; Xie YT; Tan DM
Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):734-6. PubMed ID: 15619340
[TBL] [Abstract][Full Text] [Related]
12. Serum osteopontin levels in patients with acute liver dysfunction.
Arai M; Yokosuka O; Kanda T; Fukai K; Imazeki F; Muramatsu M; Seki N; Miyazaki M; Ochiai T; Hirasawa H; Saisho H
Scand J Gastroenterol; 2006 Jan; 41(1):102-10. PubMed ID: 16373283
[TBL] [Abstract][Full Text] [Related]
13. [The plasma levels and diagnostic utility of stem cell factor (SCF) and macrophage-colony stimulating factor (M-CSF) in cervical cancer patients].
Lawicki S; Bedkowska E; Gacuta-Szumarska E; Knapp P; Szmitkowski M
Pol Merkur Lekarski; 2008 Jul; 25(145):38-42. PubMed ID: 18839612
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure.
Di Campli C; Zocco MA; Saulnier N; Grieco A; Rapaccini G; Addolorato G; Rumi C; Santoliquido A; Leone G; Gasbarrini G; Gasbarrini A
Dig Liver Dis; 2007 Dec; 39(12):1071-6. PubMed ID: 17964871
[TBL] [Abstract][Full Text] [Related]
15. Serum LECT2 level as a prognostic indicator in acute liver failure.
Sato Y; Watanabe H; Kameyama H; Kobayashi T; Yamamoto S; Takeishi T; Hirano K; Oya H; Nakatsuka H; Watanabe T; Kokai H; Yamagoe S; Suzuki K; Oya K; Kojima K; Hatakeyama K
Transplant Proc; 2004 Oct; 36(8):2359-61. PubMed ID: 15561249
[TBL] [Abstract][Full Text] [Related]
16. Serum levels of thrombopoietin and stem cell factor in acute leukemia patients with chemotherapy-induced cytopenia and complicating infections.
Foss B; Nesthus I; Bergheim J; Bruserud Ø
Platelets; 1999; 10(1):17-23. PubMed ID: 16801066
[TBL] [Abstract][Full Text] [Related]
17. Reticulated platelets as a marker of megakaryopoiesis in liver cirrhosis; relation to thrombopoietin and hepatocyte growth factor serum concentration.
Panasiuk A; Prokopowicz D; Zak J; Panasiuk B
Hepatogastroenterology; 2004; 51(58):1124-8. PubMed ID: 15239259
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of platelet-derived growth factor-BB and vascular endothelial growth factor as prognostic factors for patients with fulminant hepatic failure.
Takayama H; Miyake Y; Nouso K; Ikeda F; Shiraha H; Takaki A; Kobashi H; Yamamoto K
J Gastroenterol Hepatol; 2011 Jan; 26(1):116-21. PubMed ID: 21175804
[TBL] [Abstract][Full Text] [Related]
19. Serum hematopoietic growth factors as diagnostic and prognostic markers of acute renal allograft rejection: a potential role for serum stem cell factor.
Xu X; Huang H; Cai M; Qian Y; Han Y; Xiao L; Zhou W; Wang X; Shi B
Cytokine; 2011 Dec; 56(3):779-85. PubMed ID: 22004924
[TBL] [Abstract][Full Text] [Related]
20. Predictors of fatal outcome in fulminant hepatic failure.
Sarwar S; Khan AA; Alam A; Butt AK; Ahmad I; Niazi AK; Dilshad A
J Coll Physicians Surg Pak; 2006 Feb; 16(2):112-6. PubMed ID: 16499803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
